CASQ2
Calsequestrin-2
Also known as: CASQ2_HUMAN, PDIB2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14958
- Gene
- CASQ2
- Ensembl
- ENSG00000118729
- Chromosome
- 1
- Canonical length
- 399 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
399 residues, UniProt reviewed canonical sequence.
>O14958|CASQ2
1 MKRTHLFIVG IYFLSSCRAE EGLNFPTYDG KDRVVSLSEK NFKQVLKKYD LLCLYYHEPV
61 SSDKVTQKQF QLKEIVLELV AQVLEHKAIG FVMVDAKKEA KLAKKLGFDE EGSLYILKGD
121 RTIEFDGEFA ADVLVEFLLD LIEDPVEIIS SKLEVQAFER IEDYIKLIGF FKSEDSEYYK
181 AFEEAAEHFQ PYIKFFATFD KGVAKKLSLK MNEVDFYEPF MDEPIAIPNK PYTEEELVEF
241 VKEHQRPTLR RLRPEEMFET WEDDLNGIHI VAFAEKSDPD GYEFLEILKQ VARDNTDNPD
301 LSILWIDPDD FPLLVAYWEK TFKIDLFRPQ IGVVNVTDAD SVWMEIPDDD DLPTAEELED
361 WIEDVLSGKI NTEDDDEDDD DDDNSDEEDN DDSDDDDDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against CASQ2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 989 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 989 nTPM
- skeletal muscle: 178 nTPM
- blood vessel: 174 nTPM
- tongue: 154 nTPM
- colon: 57 nTPM
- urinary bladder: 51 nTPM
Single-cell type
- thymic myoid cells: 779 nCPM
- cardiomyocytes: 301 nCPM
- myonuclei: 278 nCPM
- vascular smooth muscle cells: 220 nCPM
- smooth muscle cells: 135 nCPM
- early spermatids: 51 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 12 nTPM
- midbrain: 7.5 nTPM
- amygdala: 5.5 nTPM
- hypothalamus: 5.2 nTPM
- cerebellum: 3.7 nTPM
- basal ganglia: 2.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CASQ2.
Disease | AllUniProt
Conditions CASQ2 is implicated in, by any mechanism.
- Ventricular tachycardia, catecholaminergic polymorphic, 2 (CPVT2) MIM:611938
Disease | GeneticClinVar
79 pathogenic / likely-pathogenic of 864 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Catecholaminergic polymorphic ventricular tachycardia 1
- Catecholaminergic polymorphic ventricular tachycardia 2
- Cardiovascular phenotype
- Catecholaminergic polymorphic ventricular tachycardia
- Long QT syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.38
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.2
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle contraction
- cellular response to caffeine
- detection of calcium ion
- intracellular calcium ion homeostasis
- negative regulation of potassium ion transport
- protein polymerization
- Purkinje myocyte to ventricular cardiac muscle cell signaling
- regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- regulation of cell communication by electrical coupling
- regulation of heart rate
- regulation of membrane repolarization
- regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- sequestering of calcium ion
- striated muscle contraction
- regulation of membrane repolarization during ventricular cardiac muscle cell action potential
Molecular functions
- calcium ion binding
- calcium-dependent protein binding
- protein homodimerization activity
- calcium ion sequestering activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CASQ2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CASQ2 as an antibody target. Whether an autoantibody or antibody against CASQ2 could matter depends on whether native CASQ2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CASQ2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CASQ2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...